previous compound ID: 451 next compound
InChIKey: DGHHQBMTXTWTJV-BQAIUKQQSA-N
SMILES: CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "J Goepp" "DY Thomas" "D Rotin" "J Liao" "R Robert" "GW Carlile" "E Matthes" "B Kus" "SD Macknight"

chemical graph of compound 451





CID is 60699
synonyms found at PubChem are:
TOPOTECAN HYDROCHLORIDE, 119413-54-6, Topotecan Hcl, Hycamtin, Hycamptamine hydrochloride, Topotecan (Hydrochloride), Topotecan monohydrochloride, UNII-956S425ZCY, Topotecan hydrochloride [USAN], Nogitecan hydrochloride, DRG-0288, SK&F S-104864-A, NSC 609699, NSC-609699, NSC609699, 956S425ZCY, SKF 104864A, NCGC00095189-01, DSSTox_CID_25952, DSSTox_RID_81248, DSSTox_GSID_45952, (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione monohydrochloride, Topotecan hydrochloride (USAN), CHEMBL1607, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, monohydrochloride, (S)-, SMR000466344, CAS-119413-54-6, SK&F-S-104864A, Evotropin, Topetecan, Potactasol (TN), (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride, (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione Hydrochloride, (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride, AC1L1TQW, AC1Q3EIA, Topotecan HCl - Hycamtin, D0Z4XW, SCHEMBL7247, Hycamtin (TN) (GlaxoSmith), MLS000759456, MLS001401447, C23H23N3O5.HCl, SPECTRUM1505820, Nogitecan hydrochloride (JAN), DTXSID1045952, AOB6645, DGHHQBMTXTWTJV-BQAIUKQQSA-N, MolPort-003-666-754, HMS1922H22, Pharmakon1600-01505820, 10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride, BCP00930, KS-00000HA7, SKF-S 104864-A, Tox21_111478, BG0599, CCG-37460, CT0202, HY-13768A, NCGC00014925, NCI609699, NK-211, NSC759263, s1231, SK&F-S-104864-A, AKOS015900415, SK&F 104864-A, Tox21_111478_1, AC-1551, AN-7238, CS-1498, KS-1410, NC00177, NSC-759263, RL00754, NCGC00014925-06, NCGC00095189-02, NCGC00095189-03, AK-48920, BC203930, BR-48920, CPD000466344, SAM001246651, AB0012839, AX8001571, LS-172415, FT-0631095, D02168, S-5061, 413T546, C-22572, I14-051, E-89/001, 9-Dimethylaminomethyl-10-hydroxycamptothecin, HCl salt, (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione hydrochloride, (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride, (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[l,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride, 1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, monohydrochloride, (4S)-